搜索临床试验以:FOLFOXIRI Cetuximab regimen
总计4691个结果
-
M.D. Anderson Cancer CenterPfizer; Genentech, Inc.完全的
-
Jacobio Pharmaceuticals Co., Ltd.招聘中
-
Theagenio Cancer Hospital未知
-
Johannes Gutenberg University MainzAIO-Studien-gGmbH完全的
-
Federation Francophone de Cancerologie DigestiveMerck Sharp & Dohme LLC; Pierre Fabre Laboratories招聘中
-
Shanghai Henlius Biotech主动,不招人
-
P.O. WitteveenMerck KGaA, Darmstadt, Germany终止
-
Shanghai Zhongshan HospitalShanghai Fifth People's Hospital,Fudan University; XuHui Central Hospital of Shanghai, Shanghai...完全的
-
Georgetown UniversityGlaxoSmithKline完全的
-
King Faisal Specialist Hospital & Research Center完全的
-
Tianjin Medical University Cancer Institute and...招聘中Sintilimab, Cetuximab, Regorafenib,Combine,mCRC中国
-
NCIC Clinical Trials GroupAustralasian Gastro-Intestinal Trials Group完全的
-
University of California, San DiegoMerck Sharp & Dohme LLC主动,不招人头颈癌 | 头颈肿瘤 | 鼻咽癌 | 头颈部鳞状细胞癌 | 口咽癌 | 口腔癌 | 喉癌 | HNSCC | 下咽癌 | 皮肤鳞状细胞癌 | 唇部SCC | 鼻窦癌美国
-
The Netherlands Cancer InstituteMerck KGaA, Darmstadt, Germany完全的
-
Curegenix Inc.Merck Sharp & Dohme LLC招聘中
-
Institut du Cancer de Montpellier - Val d'Aurelle完全的
-
Masonic Cancer Center, University of Minnesota完全的肉瘤 | 肾癌 | 乳腺癌 | 头颈癌 | 大肠癌 | 胰腺癌 | 肺癌 | 未明确的成人实体瘤,特定方案美国
-
University Hospital, ToulousePfizer; Roche Pharma AG; Federation Francophone de Cancerologie Digestive完全的
-
Groupe Oncologie Radiotherapie Tete et CouTumor Study Group Head and Neck完全的
-
The Christie NHS Foundation TrustMerck Sharp & Dohme LLC完全的
-
Federation Francophone de Cancerologie Digestive撤销
-
Teva Branded Pharmaceutical Products R&D, Inc.完全的
-
The First Affiliated Hospital of Soochow UniversityJining Medical University完全的
-
University of HoustonBrigham and Women's Hospital; Texas Woman's University主动,不招人
-
Kiadis PharmaNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Institutes... 和其他合作者撤销
-
Xiaodong SunShanghai Zhongshan Hospital; Eye & ENT Hospital of Fudan University; Shanghai Tongji Hospital,... 和其他合作者未知
-
Merck Sharp & Dohme LLC完全的